Initially, the Con A effect is not tumor cell-specific, but as hepatic inflammation proceeds following Con A-mediated destruction and activation, tumor antigens of the hepatoma cells will be processed and presented to the tumor antigen-specific CD4+ T and CD8+ T cells. The gene discussed is CD8A; the disease is hepatocellular carcinoma.